| Announce Date | 11/04/2025 |
| EPS Normalized Actual | $2.5 (Beat by $0.15) |
| EPS GAAP Actual | $2.5 (Beat by $0.15) |
| Revenue Actual | $1.76616B |
| Revenue Surprise | Beat by $1766.16M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $2.50218 |
| EPS GAAP Estimate | $2.50218 |
| Revenue Estimate | $2.071439443B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 12.8653 | 26.14 | 12.53615 | 13.33399 | 2 |
| Dec 2028 | 14.06461 | 23.91 | 13.70478 | 14.57699 | 5 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2.14 | -0.37438 | 1.76616B | 6.89% | -112.88M |
| FQ2 2025 (Jun 2025) | 0 | -2.59046 | 1.78755B | 4.22% | -123.08M |
| FQ1 2025 (Mar 2025) | 2.3 | -0.05843 | 1.79075B | 11.51% | -116.5M |
| FQ4 2024 (Dec 2024) | 2.13 | 0.03479 | 1.736B | 12.27% | -31.07M |
| FQ3 2024 (Sep 2024) | 2.08 | 0.54263 | 1.64444B | 6.11% | -1443.62M |
| FQ2 2024 (Jun 2024) | 2.29 | 2.29 | 1.71206B | 13.92% | 1712.06M |
| FQ1 2024 (Mar 2024) | 1.95 | 1.95 | 1.58463B | 9.82% | 1584.63M |
| FQ4 2023 (Dec 2023) | 1.62 | 1.62 | 1.523B | 10.18% | 1523M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
2.50218
Consensus Revenue Estimates
2.071439443B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Oct 2026) | 2.35981 | -- | 2.27035 | 2.5007 | 1 |
| FQ3 2026 (Jul 2026) | 2.37188 | 9.78 | 2.28197 | 2.51349 | 1 |
| FQ2 2026 (Jun 2026) | 2.4086 | -- | 2.27356 | 2.6281 | 1 |
| FQ1 2026 (Mar 2026) | 2.50218 | 8.08 | 2.47423 | 2.52934 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Oct 2026) | 1.98B | -- | 1.93B | 2.08B | 2 |
| FQ3 2026 (Jul 2026) | 1.99B | 11.09 | 1.93B | 2.08B | 2 |
| FQ2 2026 (Jun 2026) | 2.02B | 11.58 | 1.93B | 2.16B | 2 |
| FQ1 2026 (Mar 2026) | 2.07B | 13.55 | 2.05B | 2.09B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
3
Revenue # of Misses
5
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2.51438 | 2.14 | -0.37438 | -17.49% |
| FQ2 2025 (Jun 2025) | 2.59046 | 0 | -2.59046 | -INF% |
| FQ1 2025 (Mar 2025) | 2.35843 | 2.3 | -0.05843 | -2.54% |
| FQ4 2024 (Dec 2024) | 2.09521 | 2.13 | 0.03479 | 1.63% |
| FQ3 2024 (Sep 2024) | 1.53737 | 2.08 | 0.54263 | 26.09% |
| FQ2 2024 (Jun 2024) | 2.29 | 2.29 | 100% | |
| FQ1 2024 (Mar 2024) | 1.95 | 1.95 | 100% | |
| FQ4 2023 (Dec 2023) | 1.62 | 1.62 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $1.88B | $1.77B | $-112.88M | -6.39% |
| FQ2 2025 (Jun 2025) | $1.91B | $1.79B | $-123.08M | -6.89% |
| FQ1 2025 (Mar 2025) | $1.91B | $1.79B | $-116.5M | -6.51% |
| FQ4 2024 (Dec 2024) | $1.77B | $1.74B | $-31.07M | -1.79% |
| FQ3 2024 (Sep 2024) | $3.09B | $1.64B | $-1443.62M | -87.79% |
| FQ2 2024 (Jun 2024) | $0B | $1.71B | $1712.06M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.58B | $1584.63M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1.52B | $1523M | 100% |